News
The company is selling the devices for $2,950.
Also: Medicare Advantage insurer Zing Health partners with Papa. Verily and biopharma-company Sosei Heptares announce a research collaboration. Pharma-focused accelerator PharmStars’ next cohort will focus on neurological diseases.
The company plans to expand its services nationwide by 2023.
The deal comes about a month after Nomi announced it had raked in $110 million in Series A funding.
Also: Ghanian startup mPharma raises $35 million, and child RPM maker Kiddo scoops up $16 million.
This news comes after the FDA sent the company a warning letter regarding its smart socks.
Babylon became a strategic investor in Higi, the maker of health-checking kiosks found in groceries and pharmacies, in May 2020.
They plan to infuse AI, big data, and cloud technologies with digital therapeutics.
Investment will help the company raise awareness of its product in Europe, the Middle East and Asia.
2022 Look Ahead
Patient and provider experiences have to be top-of-mind in the year ahead, with special attention to stressed hospital workers and underserved populations, healthcare vendor leaders say.